Managing Renal Masses

Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence, a new evidence-based publication from AHRQ's Effective Health Care Program, can help clinicians make informed decisions about managing renal masses and localized renal cell carcinoma—a kidney cancer that affects approximately 65,000 new patients each year.

The publication summarizes findings of a systematic review that evaluated the benefits and adverse effects of screening and treating patients with a renal mass that potentially could be localized renal cell carcinoma.

Evidence indicates there is no clear method for predicting kidney cancer during diagnosis of renal masses. Tumor size and male sex, however, are highly associated with malignancy. In addition, evidence does not support one management strategy over another; treatment decisionmaking may be affected by patient factors such as comorbidities, life expectancy, tumor characteristics (e.g., size and location), and patient values and preferences.

Select to access Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence.

Page last reviewed July 2017
Page originally created July 2017
Internet Citation: Managing Renal Masses. Content last reviewed July 2017. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/news/managing-renal-masses.html